Back to Trials
NCT04343365Recruiting

Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board

H. Lee Moffitt Cancer Center and Research Institute

Start Date

5/5/2020

Completion Date

3/1/2028

Summary

This study will evaluate the ability of a multidisciplinary group, the Evolutionary Tumor Board (ETB), to develop therapeutic strategies in patients without curative options.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * Participant must be considered likely incurable given a standard of care. This is inclusive of participants in remission but at high risk of recurrence, with suboptimal responses to previous therapy, or with many potentially beneficial, but not curative options for care. * Participant must have a life expectancy greater than 3 months * Participant must have an ECOG performance status 0-2 * Participant and primary Oncologist are willing to consider the therapeutic strategies recommended by the ETB * Willingness to be followed over time and allowing collection of clinical data including scans and serial blood sampling. Exclusion Criteria: * None

Interventions

OTHER

Evolutionary Tumor Board (ETB)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Incurable Disease

Locations

Moffitt Cancer Center

Tampa, Florida 33613

United States